REGENEREX PHARMA, INC. Operating Lease, Expense
REGENEREX PHARMA, INC. reported Operating Lease, Expense of $1.65 thousand for the 6-month period ending 2025-09-30, per its 10-Q filed 2025-11-17.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:OperatingLeaseExpense · last filed 2025-11-17
- REGENEREX PHARMA, INC. operating lease, expense for the quarter ending 2025-09-30 was $0.00.
- REGENEREX PHARMA, INC. operating lease, expense for the quarter ending 2025-06-30 was $1.65K.
- REGENEREX PHARMA, INC. operating lease, expense for the quarter ending 2024-12-31 was $0.00.
- REGENEREX PHARMA, INC. operating lease, expense for fiscal 2024 was $18.15K.
- REGENEREX PHARMA, INC. operating lease, expense for fiscal 2023 was $0.00.
| Period end | Operating Lease, Expense 3 month | Operating Lease, Expense 6 month | Operating Lease, Expense 9 month | Operating Lease, Expense 12 month | Operating Lease, Expense 12 month as first filed |
|---|---|---|---|---|---|
| 2025-09-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-11-17 | $1.65K 10-Q · filed 2025-11-17 | |||
| 2025-06-30 | $1.65K 10-Q · filed 2025-08-14 | ||||
| 2024-12-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-02-07 | $1.65K 10-Q · filed 2025-02-07 | |||
| 2024-09-30 | $1.65K 10-Q · filed 2024-11-04 | ||||
| 2024-03-31 | $18.15K 10-K · filed 2024-06-24 | ||||
| 2023-03-31 | $0.00 10-K · filed 2024-06-24 | $1.65K 10-K · filed 2023-06-09 |